Supporting Hair & Scalp Health Through Seasonal Transitions

Hair shedding can fluctuate throughout the year, with many individuals noticing temporary increases in hair fall during seasonal transitions. Changes in daylight exposure, environmental conditions, and natural hair cycle timing may influence how hair follicles move through growth and resting phases.¹
man checking his hair on front of a mirror

Because hair growth occurs in cycles, temporary increases in shedding can represent a normal physiological process rather than an indication of permanent hair loss. Providers often consider ongoing scalp-focused care approaches centered around individualized formulation selection, consistency considerations, and patient-specific preferences.²

Customized compounding allows prescribers to tailor ingredient combinations, strengths, and dosage forms pursuant to a valid prescription for an individually identified patient.

Understanding Hair Growth Cycles

Hair follicles naturally move through phases of growth (anagen), transition (catagen), and rest (telogen). Seasonal changes may influence the timing of these cycles, which can contribute to temporary increases in shedding.¹

Many providers emphasize consistency when developing scalp-focused formulation approaches, as hair appearance considerations may evolve gradually over time.

Supportive care approaches may consider:

  • Scalp-focused formulation considerations
  • Individual tolerability factors
  • Consistency-focused care approaches
  • Patient-specific preferences
  • Dosage-form flexibility

Because patient presentation can vary widely, individualized formulation strategies may allow providers to adjust ingredients, strengths, and dosage forms as care plans evolve.

Role of Customized Compounding in Hair & Scalp Care Approaches

Compounded formulations allow prescribers to combine ingredients, modify concentrations, and select dosage forms aligned with individualized provider-directed scalp and hair care approaches.

Customization may support:

  • Combination topical preparations
  • Flexible dosage forms including solutions, foams, lotions, and sprays
  • Adjusted ingredient strengths
  • Simplified application routines
  • Scalp-focused delivery approaches

Provider consultation plays an important role in determining appropriate formulation strategies based on patient-specific considerations.

Commonly Utilized Hair & Scalp Formulation Categories

Providers may consider a range of formulation approaches depending on individualized care preferences and dosage-form considerations.

These may include:

  • Topical combination preparations
  • Oral formulation options
  • Peptide-containing scalp formulations
  • Multi-ingredient compounded preparations

Seasonal transitions often encourage patients to begin or re-evaluate scalp-focused care approaches aligned with long-term consistency considerations.

Wells Pharmacy Network currently compounds several hair and scalp-focused preparations including:

  • GHK-Cu Scalp Foam
  • GHK-Cu Topical Spray
  • Zinc Thymulin / GHK-Cu Spray
  • Latanoprost (LatanoSTIM) Hair Cream & Hair Serum
  • Latanoprost / Minoxidil (LatanoSTIM-X)
  • Multi-ingredient compounded topical preparations
  • Wells Hair RX formulations for men and women

Comparing Topical and Oral Formulation Approaches

Providers may consider both topical and oral dosage forms when developing individualized scalp and hair-focused care approaches. Selection often depends on patient preferences, tolerability considerations, lifestyle factors, and provider-directed formulation preferences.

Each approach offers different practical considerations, and some providers may incorporate multiple dosage forms as part of a coordinated care approach.

Topical vs Oral Formulation Considerations

ConsiderationTopical FormulationsOral Formulations
Administration ApproachApplied directly to the scalpTaken orally as capsules or tablets
Application FocusDesigned for scalp-level applicationSystemic administration considerations
Customization OptionsMay allow multiple ingredients within one preparationFlexible strength options available
Formulation FlexibilitySolutions, foams, lotions, sprays, and gelsCapsules and tablets
Routine IntegrationOften incorporated into daily scalp-care routinesMay align with existing medication routines
Ingredient CombinationsMulti-ingredient compounded preparations availableSingle-ingredient and combination options
Patient Preference ConsiderationsMay align with patients preferring topical application approachesMay align with patients preferring simplified dosing routines
Provider-Directed AdjustmentsIngredient combinations and strengths may be adjusted over timeStrength adjustments may be modified based on provider direction

Supporting Individualized Care Decisions

Because scalp and hair-focused care approaches often involve long-term consistency considerations, providers may evaluate patient lifestyle, formulation preferences, and tolerability factors when selecting dosage forms.

Compounded preparations allow flexibility in ingredient selection, strength customization, and dosage-form choice, supporting individualized provider-directed care approaches.

Topical and oral options may be incorporated independently or as part of a coordinated formulation strategy depending on provider preference and patient-specific considerations.

Seasonal shedding may serve as a natural point for patients and providers to discuss formulation preferences and individualized scalp-focused care approaches.

Wells Pharmacy Network prepares customized formulations pursuant to valid prescriptions for individually identified patients, supporting provider-directed care through individualized compounding approaches.

References

  1. American Academy of Dermatology Association. Hair Shedding.
    https://www.aad.org/public/diseases/hair-loss/insider/shedding
  2. Malkud S. Telogen Effluvium: A Review. Journal of Clinical and Diagnostic Research. 2015;9(9):WE01-WE03.
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4606321/
  3. Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. International Journal of Molecular Sciences. 2018;19(7):1987.
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073405/
  4. Rossi A, et al. Minoxidil Use in Dermatology, Side Effects and Recent Patents. Recent Patents on Inflammation & Allergy Drug Discovery. 2012;6(2):130-136.
    https://pubmed.ncbi.nlm.nih.gov/22409453/

Disclaimer: Compounded preparations are customized for individual patients and have not been evaluated or approved by the FDA for safety or efficacy.